Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris

New England Journal of Medicine

Volumn 332, Issue 10, 1995, Pages 635-641

  Thompson, Simon G ^a   Kienast, Joachim ^b   Pyke, Stephen D m ^a   Haverkate, Frits ^c  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c TNO   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; FIBRINOGEN; TISSUE PLASMINOGEN ACTIVATOR; VON WILLEBRAND FACTOR;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; CAUSE OF DEATH; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY DISEASE; CORONARY ARTERY THROMBOSIS; CORONARY RISK; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; ENDOTHELIUM INJURY; FEMALE; FIBRINOGEN BLOOD LEVEL; HEART INFARCTION; HEMOSTASIS; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SUDDEN DEATH;

ADULT; AGED; ANGINA PECTORIS; BLOOD COAGULATION FACTORS; C-REACTIVE PROTEIN; DEATH, SUDDEN, CARDIAC; FEMALE; FIBRINOGEN; FOLLOW-UP STUDIES; HEMOSTASIS; HUMAN; MALE; MIDDLE AGE; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RISK FACTORS; SUPPORT, NON-U.S. GOV'T; TISSUE PLASMINOGEN ACTIVATOR; VON WILLEBRAND FACTOR;

EID: 0028909230     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199503093321003     Document Type: Article

References (39)

1. Zack PM, Ischinger T, Aker UT, Dincer B, Kennedy HL The occurrence of angiographically detected intracoronary thrombus in patients with unstable angina pectoris. Am Heart J 1984; 108: 1408-1412.
2. DeWood MA, Spores J, Notske R, Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med 1980; 303: 897-902
3. Davies MJ, Thomas A Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death. N Engl J Med 1984; 310: 1137-1140.
4. Fuster V, Badimon L, Badimon JJ, Chesebro JH The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med 1992; 326: 242-50, 310
5. Yarnell JWG, Baker IA, Sweetnam PM, Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease: the Caerphilly and Speedwell collaborative heart disease studies. Circulation 1991; 83: 836-844
6. Trip MD, Manger Cats V, van Capelle FJL, Vreeken J Platelet hyperreactivity and prognosis in survivors of myocardial infarction. N Engl J Med 1990; 322: 1549-1554.
7. Thaulow E, Erikssen J, Sandvik L, Stormorken H, Cohen PF Blood platelet count and function are related to total and cardiovascular death in apparently healthy men. Circulation 1991; 84: 613-617
8. Hamsten A, de Faire U, Walldius G, Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction. Lancet 1987; 2: 3-9
9. Wiman B, Hamsten A Correlations between fibrinolytic function and acute myocardial infarction. Am J Cardiol 1990; 66: 54G-56G
10. Meade TW, Mellows S, Brozovic M, Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet 1986; 2: 533-537
11. Wilhelmsen L, Svardsudd K, Korsan-Bengtsen K, Larsson B, Welin L, Tibblin G Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med 1984; 311: 501-505
12. Stone MC, Thorp JM Plasma fibrinogen -- a major coronary risk factor. J R Coll Gen Pract 1985; 35: 565-569
13. Kannel WB, Wolf PA, Castelli WP, D'Agostino RB Fibrinogen and risk of cardiovascular disease: the Framingham Study. JAMA 1987; 258: 1183-1186.
14. Heinrich J, Balleisen L, Schulte H, Assmann G, van de Loo J Fibrinogen and factor VII in the prediction of coronary risk: results from the PROCAM study in healthy men. Arterioscler Thromb 1994; 14: 54-59 [Erratum, Arterioscler Thromb 1994;14:1392.]
15. Cortellaro M, Boschetti C, Cofrancesco E, The PLAT Study: hemostatic function in relation to atherothrombotic ischemic events in vascular disease patients: principal results. Arterioscler Thromb 1992; 12: 1063-1070.
16. Jansson JH, Nilsson TK, Olofsson BO Tissue plasminogen activator and other risk factors as predictors of cardiovascular events in patients with severe angina pectoris. Eur Heart J 1991; 12: 157-161
17. Kostis JB, Baughman DJ, Kuo PT Association of recurrent myocardial infarction with hemostatic factors: a prospective study. Chest 1982; 81: 571-575
18. Jansson JH, Nilsson TK, Johnson O von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death. Br Heart J 1991; 66: 351-355
19. Cooper J, Douglas AS Fibrinogen level as a predictor of mortality in survivors of myocardial infarction. Fibrinolysis 1991; 5: 105-108
20. ECAT Angina Pectoris Study Group. ECAT angina pectoris study: baseline associations of haemostatic factors with extent of coronary arteriosclerosis and other coronary risk factors in 3000 patients with angina pectoris undergoing coronary angiography. Eur Heart J 1993; 14: 8-17
21. Jespersen J, Bertina RM, Haverkate F, eds. ECAT assay procedures: a manual of laboratory techniques. Dordrecht, the Netherlands: Kluwer Academic, 1992.
22. Thompson SG, Duckert F, Haverkate F, Thomson JM The measurement of haemostatic factors in 16 European laboratories: quality assessment for the multicentre ECAT Angina Pectoris Study. Thromb Haemost 1989; 61: 301-306
23. Thompson SG, Calori G, Thomson JM, Haverkate F, Duckert F The impact of sequential quality assessment exercises on laboratory performance: the multicentre ECAT Angina Pectoris Study. Thromb Haemost 1991; 65: 149-152
24. Grossman W, ed. Cardiac catheterization and angiography. Philadelphia: Lea and Febiger, 1986.
25. CASS principal investigators and their associates Myocardial infarction and mortality in the Coronary Artery Surgery Study (CASS) randomized trial. N Engl J Med 1984; 310: 750-758
26. Greenland S Quantitative methods in the review of epidemiologic literature. Epidemiol Rev 1987; 9: 1-30
27. Hurlimann J, Thorbecke GJ, Hochwald GM The liver as the site of C-reactive protein formation. J Exp Med 1966; 123: 365-378
28. Pepys MB C-reactive protein fifty years on. Lancet 1981; 1: 653-657
29. Green F, Humphries S Control of plasma fibrinogen levels. Baillieres Clin Haematol 1989; 2: 945-959
30. Kruskal JB, Commerford PJ, Franks JJ, Kirsch RE Fibrin and fibrinogen-related antigens in patients with stable and unstable coronary artery disease. N Engl J Med 1987; 317: 1361-1365.
31. Theroux P, Latour JG, Leger-Gauthier C, De Lara J Fibrinopeptide A and platelet factor levels in unstable angina pectoris. Circulation 1987; 75: 156-162
32. Zalewski A, Shi Y, Nardone D, Evidence for reduced fibrinolytic activity in unstable angina at rest: clinical, biochemical, and angiographic correlates. Circulation 1991; 83: 1685-1691.
33. Berk BC, Weintraub WS, Alexander RW Elevation of C-reactive protein in “active“ coronary artery disease. Am J Cardiol 1990; 65: 168-172
34. Bowie EJW. The role of von Willebrand factor in thrombosis. In: Poller L, Thomson JM, eds. Thrombosis and its management. London: Churchill Livingstone, 1993:134-40.
35. Ridker PM, Vaughan DE, Stampfer MJ, Manson JE, Hennekens CH Endogenous tissue-type plasminogen activator and risk of myocardial infarction. Lancet 1993; 341: 1165-1168.
36. Chandler WL, Trimble SL, Loo SC, Mornin D Effect of PAI-1 levels on the molar concentrations of active tissue plasminogen activator (t-PA) and t-PA/PAI-1 complex in plasma. Blood 1990; 76: 930-937
37. Kushner I, Broder ML, Karp D Control of the acute phase response: serum C-reactive protein kinetics after acute myocardial infarction. J Clin Invest 1978; 61: 235-242
38. de Beer FC, Hind CR, Fox KM, Allan RM, Maseri A, Pepys MB Measurement of serum C-reactive protein concentration in myocardial ischaemia and infarction. Br Heart J 1982; 47: 239-243
39. Liuzzo G, Biasucci LM, Gallimore Jr., The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med 1994; 331: 417-424